Clinical Trials · NCT06903923
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Virginia
- Enrollment
- 120
- Start date
- Jul 2025
- Locations
- 1 site, United States
- Primary endpoint
- 24-month change in total vBMD at the distal radius